Healthcare -
Biotechnology - NASDAQ - US
$ 53.82
4.44 %
$ 3.34 B
Market Cap
69.0
P/E
PTGX - REVENUE
Revenue PTGX - Protagonist Therapeutics, Inc.
434 M
LAST VALUE
304.27%
2 YEAR CAGR
351.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR